Author:
Kubo Atsushi,Iwano Masayuki,Yamaguchi Toru,Sato Hiroaki,Dohi Kazuhiro
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Nephrology,Physiology
Reference26 articles.
1. Henderson LW, Koch KM, Dinarello CA, Shaldon S. Hemodialysis hypotension: the interleukin hypothesis. Blood Purif 1983;1:3–8.
2. Pereira BJG, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA: Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 1994;45:890–896.
3. Herbelin A, Nguyen AT, Zingraff J, Ureña P, Descamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor-α. Kidney Int 1990;37:116–125.
4. descamps-Latscha B, herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, Groote D, Jungers P, Dayer J. Balance between IL-1β, TNF-α, and their specific inhibitors in chronic renal failure and maintenance dialysis. J Immunol 1995; 154:882–892.
5. Powell AC, Bland LA, Oettinger CW, McAllister SK, Arduino MJ, and Favero MS. Lack of plasma interleukin-1β or tumor necrosis factor-α elevation during unfavorable hemodialysis conditions. J Am Soc Nephrol 1991;2:1007–1013.